Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ipca Laboratories

Ipca Laboratories

BSE: 524494|NSE: IPCALAB|ISIN: INE571A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 30, 16:00
1287.00
43.7 (3.51%)
VOLUME 17,304
LIVE
NSE
Mar 30, 15:59
1296.75
51.7 (4.15%)
VOLUME 490,453
News on Ipca Laboratories
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
FY07 will see 18-20% revenue growth: IPCA Labs 

12.30 pm | 30 Nov 2006

IPCA Labs in the pharmaceutical space has given guidance for the full year. They expect revenue growth of 18-20% for the year ending March 2007 and op...

Ipca Labs an outperformer, target of Rs 535: Karvy

11.57 am | 23 Oct 2006

Broking house, Karvy Stock Broking is bullish on Ipca Labs. It has recommended outperformer rating on the stock with a target price of Rs 535....

Seen growth of around 24% in sales: Ipca Labs 

2.36 pm | 18 Oct 2006

ED of Ipca Labs, AK Jain says that overall in this quarter they have had sales of around Rs 244.48 crore as against Rs 196.42 crore, so there is a gro...

Ipca Labs Q2 net up at Rs 35.4cr

12.47 pm | 18 Oct 2006

Ipca Laboratories has declared its second quarter results. The company's Q2 net profit is up at Rs 35.4 crore from Rs 17.5 crore....

Ipca Labs Q2 net seen up 46.54% at Rs 29.53cr

3.40 pm | 17 Oct 2006

Ipca Laboratories is to announce its Q2FY07 results. According to CNBC-TV18 estimates, the company's net profit is seen going up 46.54% from Rs 20.15 ...

Buy Ipca Labs; target of Rs 500: Karvy

11.09 am | 23 Sep 2006

Broking House, Karvy Stock Broking is bullish on Ipca Laboratories. It has maintained buy rating with a price target of Rs 500 on the stock....

Ipca Labs in alliance with Ranbaxy for US market

12.28 pm | 21 Sep 2006 |  Source: reuters

Drug maker Ipca Laboratories Ltd. said on Thursday it had entered into an alliance with Ranbaxy Laboratories Ltd. to market its products in the United...

Buy Ipca Labs with target of Rs 463: Kotak

9.24 am | 04 Sep 2006

Broking house Kotak is bullish on Ipca Laboratories and has maintained buy rating with a price target of Rs 463 on the stock....

Buy Ipca Labs, target of Rs 522: ASK-Raymond

3.33 pm | 28 Aug 2006

Broking house, ASK-Raymond James is bullish on Ipca Laboratories. It has initiated coverage on the stock with one-year price target of Rs 522....

Buy Ipca Labs with target of Rs 500: Karvy

9.23 am | 21 Aug 2006

Broking house, karvy Stock Broking has maintained buy rating on Ipca Laboratories with price target of Rs 500....

Ipca Labs Q1 net profit at Rs 24.3cr

4.26 pm | 28 Jul 2006

Ipca Labs has announced its first quarter results. The company's net profit is at Rs 24.3 crore against Rs 25.9 crore....

Buy Ipca Labs with a target of Rs 415: Karvy

9.13 am | 02 Jun 2006

Broking house Karvy is bullish on Ipca Labs and has recommended buy with a target of Rs 415....

Ipca Labs Q4 net profit up at Rs 17.9cr

3.22 pm | 30 May 2006

Ipca Laboratories has announced its fourth quarter results. The company's Q4 net profit is up at Rs 17.9 crore from Rs 14.6 crore....

Ipca Labs Q3 standalone net profit at Rs 2.6cr

2.33 pm | 19 Jan 2006

Ipca Labs has announced its third quarter standalone results. The company's Q3 standalone net profit is down at Rs 2.6 crore from Rs 24.5 crore....

Ipca Laboratories Q3 net seen down 28.6% at Rs 17cr

7.48 pm | 18 Jan 2006

Ipca Laboratories is to announce its Q3FY06 results. According to CNBC-TV18 estimates, its net profit is expected to go down 28.6% at Rs 17 crore....

1
Quick Links for Ipca Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.